WO2002094456A1 - Fabrication of microdevices for separation of biomolecules in an electrical field - Google Patents

Fabrication of microdevices for separation of biomolecules in an electrical field Download PDF

Info

Publication number
WO2002094456A1
WO2002094456A1 PCT/US2002/016520 US0216520W WO02094456A1 WO 2002094456 A1 WO2002094456 A1 WO 2002094456A1 US 0216520 W US0216520 W US 0216520W WO 02094456 A1 WO02094456 A1 WO 02094456A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
functionalized polymer
coating
article
biomolecules
Prior art date
Application number
PCT/US2002/016520
Other languages
French (fr)
Inventor
Joerg Lahann
Original Assignee
Joerg Lahann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10124872A external-priority patent/DE10124872A1/en
Priority claimed from DE2001124873 external-priority patent/DE10124873A1/en
Application filed by Joerg Lahann filed Critical Joerg Lahann
Publication of WO2002094456A1 publication Critical patent/WO2002094456A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/04Coating on selected surface areas, e.g. using masks
    • C23C16/045Coating cavities or hollow spaces, e.g. interior of tubes; Infiltration of porous substrates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/60Deposition of organic layers from vapour phase

Definitions

  • an immobilized biological coating which specifically recognizes at least a part of the
  • the invention further relates to the field of
  • microdevices have potential use for screening of a quantity of biologically active
  • Electrophoresis is a critical tool in biotechnology for sample preparation, isolation, and
  • sample material includes nucleotides, D ⁇ A, proteins, peptides, or
  • capillary electrophoresis is especially especially
  • MCE micro capillary electrophoresis
  • properties of silicon and glass could limit their use for microfluidic devices, including: (i) limited biocompatibility, (ii) intrinsic stiffness, (iii) unfavorable geometry, and (iv)
  • microsystems towards proteins The use of polymers for manufacturing microdevices is
  • 665340B1 reports surface modification of a polymer device by incubation with harsh
  • Surface coating methods include carbon like diamond coatings (CLD),
  • This coating procedure developed to be a one-step coating and functionalization
  • Electrophoresis is an indispensable tool of biotechnology as described in
  • CE capillary electrophoresis
  • metal sources containing more than one metal.
  • a one-step CND coating process is disclosed such that the coating has polymer interfaces
  • the highly reactive surfaces are useful for several applications such as the
  • the technology provides a generic approach to surface engineering of microdevices. While overcoming restrictions associated with gold/alkanethiolates-based techniques, the technology maintains intrinsic advantages of soft lithography, e.g. accuracy, broad availability, and
  • the interfaces contain functional groups, that are capable to react with
  • interface with the drug may be carried out in aqueous solution ideal for applications associated with proteins, peptides or DNA.
  • the monomer units may be achieved either by
  • All interfaces are preferably based on poly(para-xylylene)s or copolymers
  • the interface are built up by polymers that contain one or more different
  • repetition units where at least one of the repetition units is prepared from precursors of the type of structure (1) and/or (2), while other repetition units can be variably designed,
  • R is one of the group consisting of hydrogen, C1-C4 alkyl groups, aryl
  • the proposed procedure for coating of microdevices with functionalized polymers provides an increased surface concentration of functional groups with a defined and
  • the functional groups can be used for immobilization of capturing
  • biomolecules Capturing biomolecules shall comprise those molecules that are confined at
  • Biomolecules include biological ligands, receptors, cell adhesion molecules,
  • biomolecules allows the isolation of a given sort of biomolecules. Therefore, the capturing biomolecules must posses selectivity towards a specific biomolecule or at least a class of
  • Suitable binding pairs can be antibody/antigene, antibody/heptene,
  • adhesion molecule/ cell surface receptor carrier protein/substrate, lectine/carbohydrate,
  • protein/carbohydrate carbohydrate/carbohydrate, receptor/hormone, receptor/cytokine, protein/DNA, protein/RNA, peptide/DNA, peptide/RNA, two DNA single strains,
  • DNA/RNA, DNA/ DNA, where either of both partners of these couples may serve as capturing biomolecule.
  • the describe microdevices are especially useful for characterization of biomolecules among a biological class of biomolecules.
  • Those biological classes include growth factors, neurotransmitters, catecholamin receptors, growth factor receptors, amino acid receptors or derivatives thereof, cytokine receptors, extracellular matrix molecule receptors, integrins, integrin receptors, hormones, hormone receptors, antibodies, lectines, cytokines, leptines, serpines, enzymes, proteases, kinases, phosphatases, hydrolases, transcription factors, DNA binding proteins or peptides, RNA binding proteins or peptides, cell surface antigenes, virologe proteins such as HIV-protease or hepatitis C virus protease, or phages.
  • Classes of drugs that can be used in the practice of the present invention include, but are not limited to, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anti-convulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti-glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and anti-adhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, anti-hypertensives, analgesics, anti-pyretics, steroidal and non- steroidal anti-inflammatory agents, anti-angiogenic factors, anti-secretory factors, anticoagulants and/or antithrombotic agents, local ane
  • the polymer coating may be used to bind
  • Useful molecules include
  • hydrophobic molecules as well as hydrophilic molecules, such as hydrogels.
  • hydrophilic molecules such as hydrogels.
  • temperature-sensitive materials such as poly(N-isopropylacrylamide), ethylene oxide/
  • propylene oxide co-polymers e.g. Pluronics
  • temperature sensitive proteins e.g.
  • peptides - natural or synthetic - can be bound to the microdevice via functionalized
  • Natural hydrogels may include Collagen, Laminin-containing hydrogels,
  • spacer systems may be used to bind
  • Spacers include but are not restricted to diisocyantes, dicarboxylic acid
  • spacer is any molecule that allows for chemical connection between surface and target
  • the binding occurs via chemical interactions, such as covalent bonding.
  • the disclosed invention provides a defined chemical surface even to those microdevices that are composites of different starting materials.
  • the there like deposited polymers allow binding of biomolecules - direct or via
  • the functionalized coating can be used for microdevices made of different materials
  • materials such as polymers, composites, silicon, semiconductors, glass, or metal.
  • the once deposited film may be subject to further modification using
  • suitable functionalized polymers for fabrication of microdevices for parallel analysis of biomolecules. They further allow specific tailoring of physical and or chemical surface
  • pretreatment of the substrate may include sulfur-containing groups (e.g. sulfonic acid, thioether, sulfonate, or sulfate ester group), silicon-containing group (e.g. silyl or silyloxy), or sugar derivatives.
  • the method of choice is mainly depending on the
  • cold gas plasmas including, but not limiting to oxygen, hydrogen, nitrogen, ammoniac, carbon dioxide, ethylene,
  • acetylene, propylenes, butylenes, ethanol, acetone, sulfur dioxide plasmas; or mixtures thereof have proven to be advantageous in improving the adhesion behavior of the
  • a silicon micro-reactor is utilized. It include hosts, scaffolds etc. to increase
  • microchannels are based on the techniques of
  • the master used to cast the PDMS microchannel is fabricated using
  • the channels are
  • Replica molding is simply the casting of prepolymer
  • the PDMS is cured in an oven at 60°C for 6 h at least, and the replica is then peeled from the master.
  • Patterned deposition of materials in small ( ⁇ 100 ⁇ m) features is important for applications
  • Patterned attachment of cells is also important in cell-based sensors where the reaction of cells to stimuli in specific areas
  • a silicon micro-reactor is utilized. It includes hosts, scaffolds etc. to increase
  • microchannels is based on the techniques of soft lithography.
  • PDMS microchannel is fabricated using photolithographic technique. Photolithography seems to be the most convenient method for generating patterned microchannels.
  • the PDMS is cured in an oven at 60°C for 6 h at least, and
  • Patterned attachment of cells is also important in cell-based sensors where the reaction of cells to stimuli in specific areas of a device is necessary for detection

Abstract

Fabrication of microdevices for separation of biomolecules in an electrical field comprising a vapor deposition coating process such that the coating includes polymer interfaces containing chemical groups having sufficient intrinsic reactivity to react with target molecules.

Description

FABRICATION OF MICRODEVICES FOR SEPARATION OF BIOMOLECULES IN AN
ELECTRICAL FIELD
BACKGROUND OF THE INVENTION
The fabrication of microdevices for separation of biomolecules in an electrical field is
disclosed comprising coating of at least parts of the microdevice with a functionalized polymer. The entire functionalized polymer or parts thereof can subsequently be modified
by an immobilized biological coating, which specifically recognizes at least a part of the
biomolecules being subject to detection. The invention further relates to the field of
polymer coating of functional groups made by chemical vapor deposition (CND) and the
use of homogenously distributed functional groups for defined surface design.
Those microdevices have potential use for screening of a quantity of biologically active
molecules and are in immediate context with pharmaceutical technologies in the fields of
drug discovery, proteomics, genomics, high-throughput screening and clinical diagnostics. Electrophoresis is a critical tool in biotechnology for sample preparation, isolation, and
detection. Often used sample material includes nucleotides, DΝA, proteins, peptides, or
polysaccharides. In the field of electrophoresis, capillary electrophoresis (CE) is especially
important, where charged molecules are manipulated within a capillary due to the
influence of an applied electrical field. Even more advantageous is the micro capillary electrophoresis (MCE), where the capillary electrophoresis chamber is replaced by a
microchannel. Both, CE and MCE find increasing applications for analysis, biomedicine, pharmaceutical
technology, biology, environmental analysis, and food technology.
Devises for MCE are known from US 5126022, US 5296114, or US 5180480. The use of
polymers for fabrication of MCE devices is proposed in US 588246. Although a
pronounced emphasis lies on devices made from silicon or glass, these may not be the first choice for many microfluidic applications especially in biology or medicine. Several
properties of silicon and glass could limit their use for microfluidic devices, including: (i) limited biocompatibility, (ii) intrinsic stiffness, (iii) unfavorable geometry, and (iv)
incompatibility with soft materials needed e.g. for incorporation of valves. New materials and novel immobilization strategies are therefore necessary to extend the use of
microsystems towards proteins. The use of polymers for manufacturing microdevices is
proposed in US 588246. Polymers are often considered as an alternative due to its
favorable mechanical properties and its straightforward manufacturing by rapid prototyping. However, polymers are incompatible with organic solvents required for
organic synthesis or analysis. Moreover, the absence of surface functional groups
difficulties the immobilization of proteins, enzymes or antibodies. Furthermore, polymers
are hydrophobic and supports non-specific protein adhesion. They also suffer from the lack
of defined and constant surface properties under ambiguous conditions. Due to the high
surface-to-volume ratios in microfluidic devices, even slight inhomogeneities in the
surface result in malfunction. While surface modification of glass substrates via silane
chemistry has been well established, simple, well-defined surface modification protocols
for polymers are still in their infancies. For this reason, US 5935409 proposes a procedure
for surface modification of electrophoresis chambers. The surface modification is troublesome, poorly reliable and expensive. US 5322608, US 5447616, and EP 452055B1 similarly describe fabrication of electrophoresis chambers using surface modification. EP
665340B1 reports surface modification of a polymer device by incubation with harsh
chemicals. The resulting functional groups are then used for further modification. Other
methods for surface modification of materials are plasma aching and plasma
polymerization (see Yasuda or EP 0519087 Al), laser treatment, or ion beam treatment. The underlying mechanisms are often poorly understood and these methods are
characterized by side reactions including the production or incorporation of potentially harmful chemicals.
Rather than pure surface modification, surface coating is the method of choice for
some applications. Surface coating methods include carbon like diamond coatings (CLD),
carbon nitπde coating, deposition of several metal layers or simple spin, dip, or spray
coating of polymers. CND polymerization coatings of paracyclophane or chlorine
derivatives thereof, applied in order to achieve inert surfaces (Swarc, Gorham, Union
Carbide; US Patent application 20020050456) have excellent homogeneity, adhesion and
stability. Recently CND coating of functionalized paracyclophanes has been used in order
to immobilize bioactive proteins (Lahann Biomaterials 2001, Hocker DE 19604173 Al).
This coating procedure developed to be a one-step coating and functionalization
method offers a wide range of applications since good bulk properties of a material has
been maintained combined with enhanced contact properties. The 'activation' of surfaces
with bivalent spacer molecules offers the opportunity of further modification such as drug
immobilization. By using the interfaces for immobilization of proteins, cell receptors,
cytokines, inhibitors etc., bioactive surfaces that interact with the biological environment in a defined and active matter can be achieved. Electrophoresis is an indispensable tool of biotechnology as described in
PCT Pub. No. WO 99/40174. The devices are used in a variety of applications and
preparation of pure samples of nucleic acids, proteins, carbohydrates, the
identification of a particular analyte in a complex mixture and the like. They are
also used in capillary electrophoresis (CE) and microchannel electrophoresis
(MCE). These methods are used for industrial processes and basic research
including analytical, biomechanical, pharmaceutical, environmental, molecular,
biological, food and clinical applications.
U.S. Patent Nos. 5,858,188 and 5,935,409 further describe microchannels
and their use in electrophoresis and processes for recovering metal values from
metal sources containing more than one metal.
SUMMARY OF THE INVENTION
A one-step CND coating process is disclosed such that the coating has polymer interfaces
that contain chemical groups having sufficient intrinsic reactivity to react with target
molecules. The highly reactive surfaces are useful for several applications such as the
manufacturing of electrophoresis devices, micrototalanalysis systems, immobilization of
drugs for tissue engineering, micro-reactors, or devices for protein or DΝA screening.
When chemically addressable surfaces are needed for the production of microdevices for analysis of biomolecules, CND polymerization of functionalized
[2.2]paracyclophanes can be utilized. The technique has been used for coating several
materials with polymers. Since the coating step is substrate-independent, the technology provides a generic approach to surface engineering of microdevices. While overcoming restrictions associated with gold/alkanethiolates-based techniques, the technology maintains intrinsic advantages of soft lithography, e.g. accuracy, broad availability, and
low costs.
It is an object of this invention to provide a one step CND process resulting in
functionalized coating of microdevices for separation of biomolecules in an electrical
field.
It is another object of this invention to provide the functionalized coating on
essentially any shaped three dimensional or porous structure.
It is another object to provide a simple, inexpensive quick scale-up method of
producing a chemically addressable surface for separation of biomolecules in an electric
field.
Additionally it is another object to provide applications for the herein disclosed
methods.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Universal applicability of the reactive coating to various substrates, such as
polymers, metals, or composites makes the procedure described below attractive for
fabrication of microdevices for parallel analysis of biomolecules.
Generally, the interfaces contain functional groups, that are capable to react with
functional groups of a target molecule resulting in stable or metastable chemical linkages and are produced by chemical vapor deposition. The reaction of the interface with the
drug may or may not take advantage of bivalent linker molecules. The reaction of the
interface with the drug may be carried out in aqueous solution ideal for applications associated with proteins, peptides or DNA. The monomer units may be achieved either by
thermal or photochemical activation of suitable precursors (usually paracyclophanes) in a
CND process. All interfaces are preferably based on poly(para-xylylene)s or copolymers
thereof. The interface are built up by polymers that contain one or more different
repetition units, where at least one of the repetition units is prepared from precursors of the type of structure (1) and/or (2), while other repetition units can be variably designed,
although para-xylylene is the preferred repetition unit. Preferred examples are
summarized as examples 1 to 45.
Whereas X i preferably one of th following Br, I, Ν; acetoxy
Figure imgf000007_0001
(1)
(2)
Figure imgf000007_0002
Figure imgf000008_0001
Figure imgf000009_0001
Figure imgf000010_0001
(whereas R is one of the group consisting of hydrogen, C1-C4 alkyl groups, aryl
groups)
Depending on the used polymer, the required temperatures for monomer creation are
between 400 and 1000 °C and the pressures are below 500 Pa.
The proposed procedure for coating of microdevices with functionalized polymers provides an increased surface concentration of functional groups with a defined and
controlled ratio when compared to conventional methods such as plasma treatments. The
functional groups establish an elecrophoretically active, charge layer and defines the interaction with charged molecules in the solution. It further establishes constant flow
parameter, such as a constant electrosmotic flow. Physico-chemical properties such as
zeta-potential or surface tension are constant and truly defined by the functionalized
polymer coating. Due to the rigid background of the deposited polymer, aging effects as a
consequence of interactions with analyte solutions can be ruled out. Furthermore, the functional groups can be used for immobilization of capturing
biomolecules. Capturing biomolecules shall comprise those molecules that are confined at
a surface and bind at least a part of the biomolecules that are subject to screening.
Capturing biomolecules include biological ligands, receptors, cell adhesion molecules,
antibodies, haptenes, lectines, carbohydrates, DNA, RNA, artificial receptors, etc. A
variety of capturing biomolecules is known to an expert to the field; some of them are disclosed in WO 00/04390. The binding event between capturing biomolecules and
biomolecules allows the isolation of a given sort of biomolecules. Therefore, the capturing biomolecules must posses selectivity towards a specific biomolecule or at least a class of
biomolecules. Suitable binding pairs can be antibody/antigene, antibody/heptene,
enzyme/substrate, integrin extracellular matrix component, biomolecule/cell, cell/cell, cell
adhesion molecule/ cell surface receptor, carrier protein/substrate, lectine/carbohydrate,
protein/carbohydrate, carbohydrate/carbohydrate, receptor/hormone, receptor/cytokine, protein/DNA, protein/RNA, peptide/DNA, peptide/RNA, two DNA single strains,
DNA/RNA, DNA/ DNA, where either of both partners of these couples may serve as capturing biomolecule.
The describe microdevices are especially useful for characterization of biomolecules among a biological class of biomolecules. Those biological classes include growth factors, neurotransmitters, catecholamin receptors, growth factor receptors, amino acid receptors or derivatives thereof, cytokine receptors, extracellular matrix molecule receptors, integrins, integrin receptors, hormones, hormone receptors, antibodies, lectines, cytokines, leptines, serpines, enzymes, proteases, kinases, phosphatases, hydrolases, transcription factors, DNA binding proteins or peptides, RNA binding proteins or peptides, cell surface antigenes, virologe proteins such as HIV-protease or hepatitis C virus protease, or phages. Classes of drugs that can be used in the practice of the present invention include, but are not limited to, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anti-convulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti-glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and anti-adhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, anti-hypertensives, analgesics, anti-pyretics, steroidal and non- steroidal anti-inflammatory agents, anti-angiogenic factors, anti-secretory factors, anticoagulants and/or antithrombotic agents, local anesthetics, ophthalmics, prostaglandins, anti-depressants, anti-psychotic substances, anti-emetics, and imaging agents. A more complete listing of classes and specific drugs suitable for use in the present invention may be found in "Pharmaceutical Substances : Syntheses, Patents, Applications" by Axel Kleemann and Jurgen Engel, Thieme Medical Publishing, 1999 and the "Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals", Edited by Susan Budavari et al, CRC Press, 1996, both of which are incorporated herein by reference.
In another embodiment of the invention, the polymer coating may be used to bind
artificial or natural molecules that change the surface properties of the microdevice or
increase the surface area exposed to the analyte solution. Useful molecules include
hydrophobic molecules as well as hydrophilic molecules, such as hydrogels. Especially,
temperature-sensitive materials, such as poly(N-isopropylacrylamide), ethylene oxide/
propylene oxide co-polymers (e.g. Pluronics ), or temperature sensitive proteins or
peptides - natural or synthetic - can be bound to the microdevice via functionalized
polymer coating. Natural hydrogels may include Collagen, Laminin-containing hydrogels,
Fibrin, Elastin, Agerose, Aga, or mixtures thereof. In another embodiment of the invention, spacer systems may be used to bind
molecules. Spacers include but are not restricted to diisocyantes, dicarboxylic acid
chlorides, dioles, diamines, dithiols oder dicarboxylic acids and their active esters. A
spacer is any molecule that allows for chemical connection between surface and target
molecule. The binding occurs via chemical interactions, such as covalent bonding.
Due to the mild character of the deposition process, side reactions are suppressed and the deposited films are homogeneous with respect to their chemical structure and topology - unless otherwise intended. Gradients may be achieved by establishment of
temperature gradients at the substrate being subject to coating. Another advantage of the
disclosed method is that straightforward synthesis and selection of appropriate precursor
allows the establishment of different functional groups beside each other. This feature is
especially crucial, when immobilization of more than one type of biomolecules to the same
substrate is intended. Spatially directed immobilization of biomolecules becomes than
possible. Furthermore, the disclosed invention provides a defined chemical surface even to those microdevices that are composites of different starting materials.
When depositing polymers from precursors based on the general structures (1) or
(2), we found temperatures between 400 und 900 °C and pressures below 150 Pa suitable for activation of the precursor, while deposition was best conducted at temperatures below
160 °C. The there like deposited polymers allow binding of biomolecules - direct or via
spacers. The functionalized coating can be used for microdevices made of different
materials, such as polymers, composites, silicon, semiconductors, glass, or metal.
Furthermore, the once deposited film may be subject to further modification using
conventional methods such as plasma etching with cold plasmas, such as oxygen, water, ammoniac, argon, sulfur dioxide, nitrogen, hydrogen plasmas or mixtures thereof. In another embodiment of the invention, functionalized polymer coatings may be
prepared by co-polymerization of precursors of the general structures (1) or (2) with
precursors of the general structures (3) and/or (4). Those co-polymers were found to be
suitable functionalized polymers for fabrication of microdevices for parallel analysis of biomolecules. They further allow specific tailoring of physical and or chemical surface
properties including topology as required by a given application.
Figure imgf000014_0001
(3) (4)
wherein Rn (n=l , 2,3,4) may be equal or different and may be selected from the group consisting of hydrogen, C1-C4 alkyl, aryl, a ine, alcohol, ether, ethylene glycol, cyclic ether, thioether, crown ether, primary amide, secondary amide, ethylene glycol containing primary amide, ethylene glycol containing secondary amide, urethane, nitrile, isonitrile, nitrosamine, lactone, ethylene glycol containing urethane, carbamate, ethylene glycol containing carbamate, lactam, imine, hydrazone, ester, ethylene glycole containing ester, nitro compounds, nitrile, halo, organic radical, metalized group, acid halide group, isocyantate, thioisocyante, groups of the general nature CO(O-M-A) (with M: C1-C4 aliphatic or aromatic group and A: e.g. hydrogen, hydroxyl-, amino-, or carboxy groups), sulfur-containing groups (e.g. sulfonic acid, thioether, sulfonate, or sulfate ester group), silicon-containing group (e.g. silyl or silyloxy), or sugar derivatives. Prior to coating in the vapor deposition process, pretreatment of the substrate may
be used to improve adhesion behavior. The method of choice is mainly depending on the
type of substrate and all methods well-known to a person skilled in the field of adhesion
improvement may be applied. Especially a pretreatment with cold gas plasmas including, but not limiting to oxygen, hydrogen, nitrogen, ammoniac, carbon dioxide, ethylene,
acetylene, propylenes, butylenes, ethanol, acetone, sulfur dioxide plasmas; or mixtures thereof have proven to be advantageous in improving the adhesion behavior of the
deposited polymer coatings.
Application 1
A silicon micro-reactor is utilized. It include hosts, scaffolds etc. to increase
surface area. A CND coating is applied inside the channel. Antibodies, ligands etc are
selectively attached to each channel. Screening of solution of labeled proteins is
conducted by flowing the solutions in individual channel and then there is a read out. It is
possible to create complex geometries possible, applications for diagnostics, proteomics, and drug screening. The fabrication of the microchannels is based on the techniques of
soft lithography. The master used to cast the PDMS microchannel is fabricated using
photolithographic technique. Photolithography seems to be the most convenient method
for generating patterned microchannels. Once a master is fabricated, the channels are
formed in PDMS by replica molding. Replica molding is simply the casting of prepolymer
against a master and generating a negative replica of the master in PDMS. The PDMS is cured in an oven at 60°C for 6 h at least, and the replica is then peeled from the master.
Patterned deposition of materials in small (<100μm) features is important for applications
of miniaturized systems in biochemistry and cell biology. Patterned attachment of cells is also important in cell-based sensors where the reaction of cells to stimuli in specific areas
of a device is necessary for detection of species of interest.
A solution of (+)biotinyl-3,6,9-trioxaundecanediamine (80% ethanol / 20% DMF)
is used to flow for 4h through the microchannels which are coated with (1) reactive
coating and (2) After flushing for 3. min with PBS containing 0.1% (w/v) bovine serum albumin and 0.02% (v/v) Tween 20, a fluorescein-conjugate streptavidin solution is guided through the channel for lh.
Application 2
A silicon micro-reactor is utilized. It includes hosts, scaffolds etc. to increase
surface area. A CND coating is applied inside the channel. Antibodies, ligands etc are
selectively attached to each channel. Screening solution with tagged proteins flows in
each channel and then there is a read out. It is possible to create complex geometries
possible, applications for diagnostics, proteomics, drug screening. The fabrication of the
microchannels is based on the techniques of soft lithography. The master used to cast the
PDMS microchannel is fabricated using photolithographic technique. Photolithography seems to be the most convenient method for generating patterned microchannels. Once a
master is fabricated, the channels are formed in PDMS by replica molding. Replica
molding is simply the casting of prepolymer against a master and generating a negative
replica of the master in PDMS. The PDMS is cured in an oven at 60°C for 6 h at least, and
the replica is then peeled from the master. Patterned deposition of materials in small
(<100μm) features is important for applications of miniaturized systems in biochemistry
and cell biology. Patterned attachment of cells is also important in cell-based sensors where the reaction of cells to stimuli in specific areas of a device is necessary for detection
of species of interest.
A solution of (+)biotinyl-3,6,9-trioxaundecanediamine (80% ethanol / 20% DMF)
is used to flow for 4h through the microchannels which are coated with (1) reactive
coating and (2) After flushing for 3. min with PBS containing 0.1% (w/v) bovine serum albumin and 0.02% (v/v) Tween 20, a fluorescein-conjugate streptavidin solution is guided
through the channel for lh.

Claims

Claims
1. Fabrication of microdevices for separation of biomolecules in an electrical field comprising a vapor deposition coating process such that the coating includes polymer
interfaces containing chemical groups having sufficient intrinsic reactivity to react with
target molecules.
2. Fabrication of microdevices for separation of biomolecules in an electrical field,
wherein a functionalized polymer is prepared from precursors of the general structures (1) and/or (2) by activation at temperatures between 450 and 1000 °C and reduced pressures
below 500 Pa and deposition at lower temperatures on at least parts of the microdevice, with:
Whereas X is one of the following Br, I, N3, acetoxy
Figure imgf000018_0001
(1)
(2)
Figure imgf000018_0002
Figure imgf000019_0001
Figure imgf000020_0001
Figure imgf000021_0001
(R= hydrogen, C1-C4 alkyl groups, aryl groups)
3. Fabrication of microdevices for separation of biomolecules in an electrical field,
wherein the coatings are based on poly[para-xylylenes]s or copolymers thereof.
4. Method of claim 2, wherein [2.2]paracyclophanes are polymerized during the chemical
vapor deposition process.
5. Method of claim 2, comprising activation of precursors of the general structures (1) or
(2) at temperatures between 600 and 900 °C and pressures below 100 Pa and deposition
of the polymers at temperatures below 160 °C.
6. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
used for confinement of capturing molecules.
7. Method of claim 2, wherein a functionalized polymer is provided; said polymer reacting
with functional groups of target molecules resulting in stable linkages.
8. Method of claim 7 comprising the use of spacer systems to confine capturing molecules
to the surface.
9. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
transparent.
10. Method of claim 2, wherein a functionalized polymer is provided; said polymer having
a thickness between 20 and 2000 nm.
1 1. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
used for confinement of molecules that change surface tension of the luminal surface.
12. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
used for confinement of molecules that change the area of surface interacting with the
analyte solution.
13. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
used for confinement of hydrogels.
14. Method of claim 2, wherein a functionalized polymer is provided; said polymer used
for confinement of polyelectrolytes.
15. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
used for confinement of temperature-sensitive molecules.
16. Method of claim 7 comprising at least a part of the capturing molecules to specifically
bind to biomolecules that are subject to screening.
17. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
further modified by plasma treatment.
18. Method of claim 2, wherein a functionalized polymer is provided; said polymer being further modified by treatment with chemicals.
19. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
further modified by treatment with a high energy source.
20. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
prepared by co-polymerization of precursors of the general structures (1) or (2) with
precursors of the general structures (3) and/or (4).
Figure imgf000023_0001
(3) (4)
wherein Rn (n=l , 2,3,4) may be equal or different and may be selected from the group consisting of hydrogen, C1-C4 alkyl, aryl, amine, alcohol, ether, ethylene glycol, cyclic ether, thioether, crown ether, primary amide, secondary amide, ethylene glycol containing primary amide, ethylene glycol containing secondary amide, urethane, nitrile, isonitrile, nitrosamine, lactone, ethylene glycol containing urethane, carbamate, ethylene glycol containing carbamate, lactam, imine, hydrazone, ester, ethylene glycole containing ester, nitro compounds, nitrile, halo, organic radical, metalized group, acid halide group, isocyantate, thioisocyante, groups of the general nature CO(O-M-A) (with M: C1-C4 aliphatic or aromatic group and A: e.g. hydrogen, hydroxyl-, amino-, or carboxy groups), sulfur-containing groups (e.g. sulfonic acid, thioether, sulfonate, or sulfate ester group), silicon-containing group (e.g. silyl or silyloxy), or sugar derivatives.
21. The method of claim 2 comprising a pre-treatment of the surface with a gas plasma
prior to deposition of the functionalized coating.
22. The method of claim 2 comprising coating of a microdevice made from polymers.
23. The method of claim 2 comprising coating of a microdevice made from
polydimethylsiloxane.
24. The method of claim 2 comprising coating of a microdevice made from a
poly(acrylate) and/or poly(methacrylate).
25. The method of claim 2 comprising coating of a microdevice made from glass, silicon
and/or silicon dioxide.
26. Microdevice for separation of biomolecules in an electrical field, said microdevice comprising a polymeric coating for capturing molecules at the surface, which bind at
least a part of the biomolecules being subject to screening only temporarily allowing
their subsequent release.
27. Article of claim 26 comprising a modular design of the microdevice.
28. Article of claim 26 comprising; said article comprising at least one electrophoresis
chamber.
29. Article of claim 26 comprising; said article comprising at least on capillary.
30. Article of claim 26 comprising; said article comprising at least one microchannel.
31. Article of claim 26 comprising; said article comprising between 2 und 1000
microchannels per square centimeter.
32. Article of claim 26 comprising; said article comprising at least one of the following
elements in variable quantity and geometry: inlet reservoir, outlet reservoir,
electrophoresis chamber, parallel enrichment channel, or electrodes.
33. Method of claim 2, wherein a functionalized polymer is provided; said polymer covering only a part of the microdevice surface.
34. Method of claim 2 comprising more than one functionalized polymer coating deposited at different regions of the device surface.
35. Method of claim 2, wherein a functionalized polymer is provided; said polymer being
deposited in different microchannels.
36. Method of claim 2, wherein a functionalized polymer is provided; said polymer comprising an anisotropic distribution of chemical groups on the surface.
37. Method of claim 36, wherein a functionalized polymer is provided; said polymer comprising a chemical and/or biological gradient.
PCT/US2002/016520 2001-05-22 2002-05-22 Fabrication of microdevices for separation of biomolecules in an electrical field WO2002094456A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10124872A DE10124872A1 (en) 2001-05-22 2001-05-22 Fabrication of microdevices for separation of biomolecules in an electric field involves a vapor deposition coating process with the coating including functional groups having an intrinsic reactivity to react with target molecules
DE2001124873 DE10124873A1 (en) 2001-05-22 2001-05-22 Fabrication of microdevices for parallel analysis of biomolecules involves a vapor deposition coating process with the coating including functional groups having an intrinsic reactivity to react with target molecules
DE10124872.5 2001-05-22
DE10124873.3 2001-05-22

Publications (1)

Publication Number Publication Date
WO2002094456A1 true WO2002094456A1 (en) 2002-11-28

Family

ID=26009363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/016520 WO2002094456A1 (en) 2001-05-22 2002-05-22 Fabrication of microdevices for separation of biomolecules in an electrical field

Country Status (1)

Country Link
WO (1) WO2002094456A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5267390A (en) * 1991-04-15 1993-12-07 Yang Duck J Organic vapor deposition process for corrosion protection of prestamped metal substrates
US5393533A (en) * 1988-09-09 1995-02-28 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
US5512753A (en) * 1994-06-08 1996-04-30 Packard Instrument, B.V. Scintillation counting system using scintillator capsules
US5743905A (en) * 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US5925420A (en) * 1996-07-16 1999-07-20 Wj Semiconductor Equipment Group, Inc. Method for preparing crosslinked aromatic polymers as low κ dielectrics
US5945605A (en) * 1997-11-19 1999-08-31 Sensym, Inc. Sensor assembly with sensor boss mounted on substrate
USH1824H (en) * 1997-08-01 1999-12-07 The United States Of America As Represented By The Secretary Of The Navy Vapor deposition of a thin polymer film on solid propellant rocket grain surface
US6123993A (en) * 1998-09-21 2000-09-26 Advanced Technology Materials, Inc. Method and apparatus for forming low dielectric constant polymeric films

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393533A (en) * 1988-09-09 1995-02-28 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
US5267390A (en) * 1991-04-15 1993-12-07 Yang Duck J Organic vapor deposition process for corrosion protection of prestamped metal substrates
US5512753A (en) * 1994-06-08 1996-04-30 Packard Instrument, B.V. Scintillation counting system using scintillator capsules
US5743905A (en) * 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US5925420A (en) * 1996-07-16 1999-07-20 Wj Semiconductor Equipment Group, Inc. Method for preparing crosslinked aromatic polymers as low κ dielectrics
USH1824H (en) * 1997-08-01 1999-12-07 The United States Of America As Represented By The Secretary Of The Navy Vapor deposition of a thin polymer film on solid propellant rocket grain surface
US5945605A (en) * 1997-11-19 1999-08-31 Sensym, Inc. Sensor assembly with sensor boss mounted on substrate
US6123993A (en) * 1998-09-21 2000-09-26 Advanced Technology Materials, Inc. Method and apparatus for forming low dielectric constant polymeric films

Similar Documents

Publication Publication Date Title
Shakeri et al. Conventional and emerging strategies for the fabrication and functionalization of PDMS-based microfluidic devices
US11780984B2 (en) Integration of ex situ fabricated porous polymer monoliths into fluidic chips
Kim et al. Soft lithography for microfluidics: a review
US6977138B2 (en) Reactive polymer coatings
US6368877B1 (en) Self-assembling peptide surfaces for cell patterning and interactions
Didar et al. Patterning multiplex protein microarrays in a single microfluidic channel
US7192629B2 (en) Devices utilizing self-assembled gel and method of manufacture
Chen et al. Fabrication of discontinuous surface patterns within microfluidic channels using photodefinable vapor-based polymer coatings
Popat et al. Poly (ethylene glycol) interfaces: an approach for enhanced performance of microfluidic systems
Muck et al. Chemical modification of polymeric microchip devices
Tu et al. Surface modification of poly (dimethylsiloxane) and its applications in microfluidics-based biological analysis
US20050118595A1 (en) Fabrication of surfaces with reduced protein adsorption and/or cell adhesion
Anwar et al. Reversible sealing techniques for microdevice applications
US20060237080A1 (en) Patterned surfaces and polymeric microstructures within robust microfluidic channels
Kanitthamniyom et al. Application of polydopamine in biomedical microfluidic devices
JP2010216964A (en) Functional microchip and method of manufacturing the same
US8795787B2 (en) Surface modification
Abdallah et al. Surface coatings for microfluidic-based biomedical devices
Gumuscu et al. Photopatterning of hydrogel microarrays in closed microchips
WO2002094454A1 (en) Fabrication of microdevices for parallel analysis of biomolecules
US20060252046A1 (en) Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying gradient of immobilised biomolecules
JP2006526994A5 (en)
Kang et al. Poly (ethylene glycol)(PEG) microwells in microfluidics: Fabrication methods and applications
WO2002094456A1 (en) Fabrication of microdevices for separation of biomolecules in an electrical field
Shirtcliffe et al. Surface treatments for microfluidic biocompatibility

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP